LAVA Therapeutics Announces Annual Meeting of Shareholders
01 June 2022 - 6:05AM
LAVA Therapeutics N.V. (Nasdaq: LVTX) (LAVA), a clinical stage
immuno-oncology company focused on developing its proprietary
Gammabody™ platform of bispecific gamma delta T cell engagers to
transform the treatment of cancer, today announced the Annual
General Meeting of Shareholders will take place on Wednesday, June
15, 2022, at 7:30 a.m. CEST, at Beethovenstraat 400, 1082 PR,
Amsterdam, the Netherlands.
All relevant documents and information relating to the annual
general meeting, including the notice and agenda for the annual
general meeting, are available in the “Investors” section of LAVA’s
website (www.lavatherapeutics.com) under “Annual Meeting.” The
documents will also be made available on the SEC’s website
(www.sec.gov). Shareholders who wish to attend the meeting should
register as described in the notice and agenda for the annual
general meeting.
About LAVA TherapeuticsLAVA Therapeutics N.V.
is a clinical stage immuno-oncology company utilizing its
proprietary Gammabody™ platform to develop a portfolio of
bispecific gamma delta T cell engagers for the potential treatment
of solid and hematologic malignancies. The Company utilizes
bispecific antibodies engineered to selectively kill cancer cells
by triggering Vγ9Vδ2 (Vgamma9 Vdelta2) T cell antitumor effector
functions upon cross-linking to tumor-associated antigens.
LAVA-051, the Company’s lead candidate for the treatment of
multiple myeloma, chronic lymphocytic leukemia and acute myeloid
leukemia, is enrolling patients in a Phase 1/2a clinical study
(NCT04887259). A Phase 1/2a clinical study to evaluate LAVA-1207 in
patients with metastatic castration-resistant prostate cancer
(mCRPC) is also enrolling (NCT05369000). For more information,
please visit www.lavatherapeutics.com, and follow us on
LinkedIn, Twitter and YouTube.
CONTACTSInvestor
Relationsir@lavatherapeutics.com
Argot Partners (IR/Media)212-600-1902lava@argotpartners.com
LAVA Therapeutics NV (NASDAQ:LVTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
LAVA Therapeutics NV (NASDAQ:LVTX)
Historical Stock Chart
From Apr 2023 to Apr 2024